Corneal Cross-Linking for Keratoconus — What to Expect

Keratoconus affects approximately 1 in 2,000 Australians and is most active in teenagers and young adults. Without intervention, progressive corneal thinning and steepening leads to increasing visual distortion, contact lens intolerance, and in severe cases, the need for corneal transplantation.

Corneal cross-linking (CXL) changed this trajectory. Introduced in the early 2000s and now widely performed, CXL is the only treatment that halts keratoconus progression in the vast majority of patients. Early identification and timely cross-linking preserve vision that would otherwise be lost.

Understanding Keratoconus Progression

Keratoconus is not static. The cornea progressively thins and steepens, distorting its normal spherical shape into an irregular cone. This progression causes increasing astigmatism and myopia that becomes harder to correct with glasses, and eventually compromises the fit and tolerance of contact lenses.

The speed of progression varies considerably between patients. Young patients, those who rub their eyes, and those with atopy (eczema, hay fever, allergic eye disease) tend to progress faster. In many patients, keratoconus stabilises naturally by the mid-thirties — but waiting for natural stabilisation risks unnecessary vision loss.

The Cross-Linking Procedure

Standard (Epithelium-Off) Protocol

The most widely used and best-evidenced protocol involves removing the corneal epithelium (surface layer) to allow riboflavin penetration:

1. Topical anaesthetic drops are instilled
2. The corneal epithelium is removed over a central 9mm zone using a blunt instrument or dilute alcohol
3. Riboflavin 0.1% drops are instilled every 3 minutes for 30 minutes
4. UVA light (370nm, 3 mW/cm²) is applied for 30 minutes (total fluence 5.4 J/cm²)
5. A bandage contact lens is placed

The procedure takes approximately 75–90 minutes per eye. Both eyes are not treated simultaneously — typically one eye is treated, with the second eye scheduled several weeks later once the first has healed.

Accelerated Cross-Linking

Higher-intensity, shorter-duration protocols (e.g. 9 mW/cm² for 10 minutes) deliver the same total energy more rapidly. Results appear broadly equivalent to standard cross-linking for typical keratoconus, and accelerated protocols are increasingly used for patient convenience.

Epithelium-On (Transepithelial) Cross-Linking

"Epi-on" protocols leave the epithelium intact, using modified riboflavin formulations to penetrate the surface. Recovery is faster and less uncomfortable. However, the evidence base is not as strong as for epithelium-off CXL, and efficacy may be lower in some patient subgroups. Its role continues to be defined.

After Cross-Linking — What to Expect

Days 1–5: Discomfort, tearing, and light sensitivity while the epithelium heals under the bandage contact lens. Vision is significantly blurred.

Weeks 1–6: The bandage lens is removed after surface healing. Vision remains variable during this period as the corneal stroma remodels. Do not judge outcomes during this phase.

Months 3–12: Vision gradually stabilises. Corneal topography is reassessed at 3 months and 12 months to confirm arrest of progression.

Long term: The strengthening effect of CXL is durable — studies show stability maintained at 10+ years in the majority of patients.

Cross-Linking and Contact Lenses

Cross-linking does not change the optical prescription or corneal shape significantly. Patients who were managing with rigid gas-permeable (RGP) or scleral lenses before CXL will typically continue to need specialty lenses afterwards. The benefit is that lens fits remain stable rather than requiring ongoing changes to accommodate a progressively steepening cornea.

When Cross-Linking Is Not Enough

In advanced keratoconus — where the corneal shape is too irregular for adequate contact lens correction, or where corneal scarring is present — corneal transplantation may be required. Deep anterior lamellar keratoplasty (DALK) preserves the patient's own endothelium and is preferred over full-thickness transplantation for keratoconus when technically feasible. Cross-linking has significantly reduced the proportion of keratoconus patients who progress to transplantation.

---

Dr Ross MacIntyre provides keratoconus assessments and management at Northern Eye Consultants, Bundoora. Book an appointment →